Finance

Lists
ABL:ETR
Abbott Laboratories
€98,70
+0,22%
(+0,22) 1D
16 Nov., 17:35:59 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABL...
Open
€99,20
High
€99,80
Low
€98,60
Mkt. cap
188,11 mjd
Avg. vol.
804,00
Volume
77,00
52-wk high
€113,36
52-wk low
€70,10
No. of employees
115 k
Open
€99,20
High
€99,80
Low
€98,60
Mkt. cap
188,11 mjd
Avg. vol.
804,00
Volume
77,00
52-wk high
€113,36
52-wk low
€70,10
No. of employees
115 k
News stories
From web sources and news partners
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEORobert B. Ford
Employees115 k
Founded1888
HeadquartersChicago, Illinois, Verenigde State van Amerika
SectorHealth Care
IndustryMedical device
Websiteabbott.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
11,46 mjd
11,16 mjd
12,59 mjd
13,01 mjd
Cost of goods sold
4,91 mjd
4,89 mjd
5,32 mjd
5,63 mjd
Cost of revenue
4,91 mjd
4,89 mjd
5,32 mjd
5,63 mjd
Research and development expenses
720,00 m
767,00 m
892,00 m
920,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,93 mjd
3,58 mjd
3,87 mjd
4,11 mjd
Operating expense
4,07 mjd
4,77 mjd
5,42 mjd
5,87 mjd
Total operating expenses
8,98 mjd
9,66 mjd
10,74 mjd
11,50 mjd
Operating income
2,48 mjd
1,50 mjd
1,85 mjd
1,52 mjd
Other non operating income
-15,00 m
-
-25,00 m
5,00 m
EBT including unusual items
2,36 mjd
1,45 mjd
1,52 mjd
1,23 mjd
EBT excluding unusual items
2,44 mjd
1,45 mjd
1,52 mjd
1,23 mjd
Income tax expense
582,00 m
372,00 m
596,00 m
311,00 m
Effective tax rate
24,68%
25,67%
39,11%
25,26%
Other operating expenses
-
-
-
-
Net income
1,78 mjd
1,08 mjd
928,00 m
920,00 m
Net profit margin
15,50%
9,65%
7,37%
7,07%
Earnings per share
1,50
1,15
1,31
1,42
Interest and investment income
78,00 m
106,00 m
52,00 m
53,00 m
Interest expense
-120,00 m
-174,00 m
-351,00 m
-350,00 m
Net interest expenses
-42,00 m
-68,00 m
-299,00 m
-297,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
3,27 mjd
2,31 mjd
2,91 mjd
2,77 mjd
Gain or loss from assets sale
65,00 m
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme